Announcements Trials
Browse Landscape

Status

Terminated 2Recruiting 2Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 2Classical hematology 1

Conditions

Prostatic Neoplasms 2Chronic Disease 1

Interventions

Docetaxel 69pembrolizumab 48Prednisone 43Nivolumab 40enzalutamide 38Gemcitabine 37Sunitinib 36Cyclophosphamide 29Radiotherapy 26Magnetic Resonance Spectroscopy 26Leuprolide 25Abiraterone Acetate 25Sorafenib 23Everolimus 23Cisplatin 23bicalutamide 19atezolizumab 18Carboplatin 18Bevacizumab 18avelumab 17Radiosurgery 17Goserelin 17Interleukin-2 16abiraterone 15fludarabine 14Doxorubicin 14olaparib 13durvalumab 13cabozantinib 13acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Registries × Genitourinary × Clear all
NCT03553732 2022-08-04

An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital

University of California, San Francisco

Terminated
48 enrolled
Genitourinary

Chronic Disease, Prostatic Neoplasms

NCT02454595 2017-09-05

Registry to Measure the Impact of Adding Genomic Testing

Myriad Genetic Laboratories, Inc.

Terminated
116 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡